領航醫藥生物科技：中期報告2020-2021.pdf

1、(Incorporated in the Cayman Islands and continued in Bermuda with limited liability)(於開曼群島註冊成立並於百慕達存續之有限公司)(Stock Code 股份代號：399)2020/21Interim Report中期報告(Incorporated in the Cayman Islands and continued in Bermuda with limited liability)(於開曼群島註冊成立並於百慕達存續之有限公司)(Stock Code 股份代號：399)CMYCMMYCYCMYKInnova

2、tivePharmBio IR2020-21 Cover v01.pdf 1 22/12/2020 下午6:12Contents目錄2Corporate Information公司資料4Chairmans Statement主席報告6Management Discussion and Analysis管理層討論及分析12Other Information Provided in Accordance with the Listing Rules根據上市規則披露之其他資料19Condensed Consolidated Statement of Profit or Loss and Other

3、Comprehensive Income簡明綜合損益及其他全面收益表22Condensed Consolidated Statement of Financial Position簡明綜合財務狀況表25Condensed Consolidated Statement of Changes in Equity簡明綜合權益變動表27Condensed Consolidated Statement of Cash Flows簡明綜合現金流量表28Notes to the Condensed Consolidated Financial Statements簡明綜合財務報表附註Corporate In

4、formation公司資料2INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED 2020/21 Interim ReportBOARD OF DIRECTORSExecutive DirectorsGao Yuan XingTang RongHuang He(retired on 31 August 2020)Non-executive DirectorsJiang Nian(Chairman)Xiao YanWu YanminIndependent non-executive DirectorsChen WeijunZhang Zhihong(resigned

5、 on 11 November 2020)Wang RongliangAudit CommitteeChen Weijun(Chairman)Zhang Zhihong(resigned on 11 November 2020)Wang RongliangRemuneration CommitteeZhang Zhihong(Chairman)(resigned on 11 November 2020)Jiang NianWang RongliangNomination CommitteeZhang Zhihong(Chairman)(resigned on 11 November 2020)

6、Jiang NianWang RongliangHONORARY CHAIRMANMao YuminCOMPANY SECRETARYPoon Hon YinREGISTERED OFFICEClarendon House2 Church StreetHamilton HM 11,Bermuda董事會執行董事高源興唐榕黃鶴（於二零二零年八月三十一日退任）非執行董事蔣年（主席）肖焱鄔燕敏獨立非執行董事陳偉君張志鴻（於二零二零年十一月十一日辭任）王榮樑審核委員會陳偉君（主席）張志鴻（於二零二零年十一月十一日辭任）王榮樑薪酬委員會張志鴻（主席）（於二零二零年十一月十一日辭任）蔣年王榮樑提名委員會張志